SBC MEDICAL GROUP HOLDINGS I (SBC) Stock Overview
NASDAQ:SBC - US73245B1070 - Common Stock
SBC Key Statistics, Chart & Performance
The current stock price of SBC is 4.1 USD. In the past month the price decreased by -6.39%.
SBC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.29 | 90.75B | ||
| CI | THE CIGNA GROUP | 10.69 | 80.16B | ||
| LH | LABCORP HOLDINGS INC | 18.39 | 23.14B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.07 | 20.17B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 12.55 | 14.95B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 112.91 | 14.80B | ||
| HIMS | HIMS & HERS HEALTH INC | 56.69 | 10.25B | ||
| DVA | DAVITA INC | 14.31 | 9.92B | ||
| GH | GUARDANT HEALTH INC | N/A | 7.91B | ||
| CHE | CHEMED CORP | 19.95 | 6.50B | ||
| RDNT | RADNET INC | 196.03 | 5.43B | ||
| CRVL | CORVEL CORP | 49.32 | 4.61B |
Related stock screener links
About SBC
Company Profile
SBC Medical Group Holdings, Inc. engages in management services and products to cosmetic treatment centers. The company is headquartered in Irvine, California and currently employs 863 full-time employees. The company went IPO on 2022-09-26. The firm is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.
Company Info
SBC MEDICAL GROUP HOLDINGS I
200 Spectrum Center Dr., Suite 300
Irvine CALIFORNIA US
Employees: 863
Phone: 19495930250
SBC MEDICAL GROUP HOLDINGS I / SBC FAQ
What is the stock price of SBC MEDICAL GROUP HOLDINGS I today?
The current stock price of SBC is 4.1 USD. The price decreased by -0.73% in the last trading session.
What is the ticker symbol for SBC MEDICAL GROUP HOLDINGS I stock?
The exchange symbol of SBC MEDICAL GROUP HOLDINGS I is SBC and it is listed on the Nasdaq exchange.
On which exchange is SBC stock listed?
SBC stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for SBC MEDICAL GROUP HOLDINGS I stock?
null analysts have analysed SBC and the average price target is 6.63 USD. This implies a price increase of 61.71% is expected in the next year compared to the current price of 4.1. Check the SBC MEDICAL GROUP HOLDINGS I stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SBC MEDICAL GROUP HOLDINGS I worth?
SBC MEDICAL GROUP HOLDINGS I (SBC) has a market capitalization of 425.91M USD. This makes SBC a Small Cap stock.
How many employees does SBC MEDICAL GROUP HOLDINGS I have?
SBC MEDICAL GROUP HOLDINGS I (SBC) currently has 863 employees.
What are the support and resistance levels for SBC MEDICAL GROUP HOLDINGS I (SBC) stock?
SBC MEDICAL GROUP HOLDINGS I (SBC) has a support level at 4.09 and a resistance level at 4.55. Check the full technical report for a detailed analysis of SBC support and resistance levels.
Is SBC MEDICAL GROUP HOLDINGS I (SBC) expected to grow?
The Revenue of SBC MEDICAL GROUP HOLDINGS I (SBC) is expected to decline by -15.47% in the next year. Check the estimates tab for more information on the SBC EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SBC MEDICAL GROUP HOLDINGS I (SBC) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SBC, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SBC, evaluating the profitability, health, valuation and growth aspects
- SBC MEDICAL GROUP HOLDINGS I (SBC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SBC MEDICAL GROUP HOLDINGS I (SBC) Sales and EPS estimates to see what analysts future expectations are.
- SBC MEDICAL GROUP HOLDINGS I (SBC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SBC MEDICAL GROUP HOLDINGS I (SBC) Insider and Institutional Ownership to learn about the owners and their transactions.
- SBC MEDICAL GROUP HOLDINGS I (SBC) Stock Chart to make your own analysis
- SBC MEDICAL GROUP HOLDINGS I (SBC) Latest news and press-releases to stay up to date.
Does SBC MEDICAL GROUP HOLDINGS I (SBC) stock pay dividends?
SBC does not pay a dividend.
When does SBC MEDICAL GROUP HOLDINGS I (SBC) report earnings?
SBC MEDICAL GROUP HOLDINGS I (SBC) will report earnings on 2025-11-11.
What is the Price/Earnings (PE) ratio of SBC MEDICAL GROUP HOLDINGS I (SBC)?
The PE ratio for SBC MEDICAL GROUP HOLDINGS I (SBC) is 9.11. This is based on the reported non-GAAP earnings per share of 0.45 and the current share price of 4.1 USD. Check the full fundamental report for a full analysis of the valuation metrics for SBC.
What is the Short Interest ratio of SBC MEDICAL GROUP HOLDINGS I (SBC) stock?
The outstanding short interest for SBC MEDICAL GROUP HOLDINGS I (SBC) is 1.91% of its float. Check the ownership tab for more information on the SBC short interest.
SBC Technical Analysis
SBC Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to SBC. SBC is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
SBC Financial Highlights
Over the last trailing twelve months SBC reported a non-GAAP Earnings per Share(EPS) of 0.45. The EPS increased by 39.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 17.71% | ||
| ROA | 10.57% | ||
| ROE | 13.63% | ||
| Debt/Equity | 0.03 |
SBC Forecast & Estimates
null analysts have analysed SBC and the average price target is 6.63 USD. This implies a price increase of 61.71% is expected in the next year compared to the current price of 4.1.
For the next year, analysts expect an EPS growth of -26.05% and a revenue growth -15.47% for SBC